Drugs / Stem Cell Infusion
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01287104 Background | Jan 2011 → Jun 2018 | leukemia, lymphoma | National Cancer Institute (NCI) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Stem Cell Infusion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01287104 ↗ |
| Modality | Cell therapy | “allogenic HSCT using the donated stem cells” NCT01287104 ↗ |
| Route | Intravenous | “stem cells by IV infusion” NCT01287104 ↗ |